Insmed Incorporated
Market Cap
$29.44B
P/E Ratio
-36.15
EPS
$-3.78
Dividend Yield
0.00%
52-Week Range
$16.59 — $137.67
Volume
913
Avg Volume
1.36K
Beta
1.10
Get alerted when 0JAV.L hits your target price.
Free — enter your email to get started
P/E (TTM)
-36.15
Forward P/E
—
PEG Ratio
7.12
P/S (TTM)
53.72
P/B (TTM)
43.69
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.68%
ROA (TTM)
-0.56%
ROIC
—
Gross Margin
0.79%
Operating Margin
-1.94%
Net Margin
—
Debt/Equity
1.04
Current Ratio
3.83
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.14%
EPS Growth (5Y)
-0.14%
Sales Growth (3Y)
+0.25%
Sales Growth (5Y)
+0.22%
EPS Est (This Year)
$-2.46
EPS Est (Next Year)
$0.70
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$6.69
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-63703
Outstanding Shares
213.28M
Float
191.33M
Free Float %
89.71%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
LSE
IPO Date
2018-01-29
Employees
1271
CEO
William H. Lewis
Index Membership
—
Website
https://www.insmed.com
Insmed Incorporated (0JAV.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $29.44B, a P/E ratio of -36.15, 0JAV.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0JAV.L against other stocks using dozens of fundamental and technical filters.
0QZU.L
Vertex Pharmaceuticals Incorporated
$428.00
+1.25%
$110.00B
0R2M.L
Regeneron Pharmaceuticals, Inc.
$685.53
+1.37%
$74.06B
0M3Q.L
Zoetis Inc.
$115.60
+1.72%
$55.54B
0J2O.L
Halozyme Therapeutics, Inc.
$64.11
+1.60%
$7.57B
0HD2.L
Alnylam Pharmaceuticals, Inc.
$310.82
+4.76%
$41.22B
0RD1.L
Camurus AB (publ)
$530.55
+0.06%
$31.64B
Insmed Incorporated (0JAV.L) has a trailing twelve-month (TTM) P/E ratio of -36.15. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Insmed Incorporated (0JAV.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Insmed Incorporated (0JAV.L) has a market capitalization of $29.44 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.